June 2026 FDA Recall Chlorthalidone by Inventia Healthcare Limited
D-0610-2026 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Inventia Healthcare Limited on June 5, 2026 for the product Chlorthalidone. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0610-2026

Reason for Recall
Failed Dissolution Specifications
Initiated
06-05-2026
Reported
06-24-2026
Quantity
11,460 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Inventia Healthcare Limited
Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10

Batch or Lot Expiration Information

Batch# [100 tablet bottle] Batch RISA24001; [1000 tablet bottle] Batch RISB24002; Exp. 04/2027